• SENSEX 80,710.25
    -308.47 (--0.38%)
  • BANKNIFTY 55,360.25
    -259.10 (--0.47%)
  • One 97
    1,050.95 481.75(%)
  • HDFC Bank
    1,967.00 1,593.20(%)
  • ICICI Bank
    1,440.95 1,153.30(%)
  • Aditya Infotech
    1,104.20 1,104.20(%)
  • Newgen Software
    968.75 1,795.50(%)
  • Godfrey Phillips
    9,891.25 9,891.25(%)
  • Reliance Industr
    1,388.10 1,115.55(%)
  • Jayaswal Neco
    55.85 55.85(%)
  • Tanla Platforms
    685.95 990.00(%)
  • Tata Inv.Corpn.
    7,625.00 8,075.90(%)
  • Infosys
    1,454.75 1,307.10(%)
  • KIOCL
    410.00 453.05(%)
  • APL Apollo Tubes
    1,633.60 1,935.00(%)
  • IndusInd Bank
    848.80 1,498.70(%)
  • Tata Motors
    659.00 1,142.00(%)
  • Chambal Fert.
    570.00 742.45(%)
  • Medplus Health
    865.95 603.00(%)
  • New India Assura
    205.00 278.00(%)
  • M & M
    3,221.15 3,302.90(%)
  • SBI
    803.65 875.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ANG Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70392.0
  • ISIN : INE236W01016
30.06 -1 (-1.99%)
  • As on 05 Aug 2025 (EOD)

  • Today’s Low

    30.06

  • Today’s High

    30.21

  • Open

    30.06

  • Perv Close

    30.67

  • 52W Low

    21.03

  • 52W High

    62.75

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    39.25

  • Div & Yield %

    0.00

  • Book Value(₹)

    51.16

  • Debt-Equity Ratio

    -1.99

  • AGM Date

    04-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.88

  • Mar.Cap (₹Cr.)

    39.25

  • RONW (%)

    -10.56

  • ROCE (%)

    1.43

Score Board

  • Equity (₹ in Cr.)

    13.06

  • BV (₹)

    51.20

  • Sales( ₹ in Cr.)

    89.91

  • NP (in Cr.)

    -10.34

  • NP Var(%)

    -46.0

  • Div%

    0.0

  • CPS (₹)

    -3.10

  • EPS (₹)

    -7.90

  • Traded Value (₹ in Lakhs)

    39.25

  • 52 Week High

    62.75

  • 52 Week Low

    21.03

  • Price BSE

    30.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    39.25

  • P/C Ratio

    -9.60

  • P/E Ratio

    -3.80

  • Price Vs.BV

    -7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 131.37 207.01 348.67 154.28 126.83 121.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 131.37 207.01 348.67 154.28 126.83 121.70
Other Income 0.84 9.84 0.95 0.75 0.42 0.23
Stock Adjustments 6.74 4.22 4.47 4.30 0.59 1.05
Total Income 138.95 221.07 354.09 159.33 127.84 122.98
EXPENDITURE :            
Raw Materials 93.93 151.12 234.49 108.26 89.56 88.89
Power and Fuel Cost 3.61 5.99 5.68 4.88 3.66 2.71
Employee Cost 15.90 20.27 18.32 14.35 7.10 6.39
Other Manufacturing Expenses 0.91 1.85 2.96 1.60 1.03 0.80
Selling and Administration Expenses 13.04 18.21 23.49 13.56 10.60 8.73
Miscellaneous Expenses 2.89 2.12 2.65 0.59 3.04 3.58
Employee Benefit Expenses 15.90 20.27 18.32 14.35 7.10 6.39
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 130.28 199.56 287.60 143.24 114.99 111.10
Operating Profit 8.66 21.51 66.49 16.08 12.85 11.87
Interest 9.77 10.92 8.31 3.98 3.22 2.64
Gross Profit -1.11 10.59 58.18 12.10 9.63 9.23
Depreciation 7.75 8.52 5.12 2.24 1.23 1.12
Profit Before Tax -8.86 2.07 53.06 9.86 8.40 8.11
Current Tax 0.00 2.11 13.47 3.18 2.40 2.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.22 0.62 -0.11 -0.57 -0.09 0.03
Reported Net Profit -8.65 -0.66 39.71 7.25 6.10 5.65
Extraordinary Items -1.56 -0.27 0.00 0.00 0.00 0.00
Adjusted Net Profit -7.09 -0.39 39.71 7.25 6.10 5.65
Adjustment below Net Profit 0.19 0.72 0.21 -0.70 -0.26 0.00
P & L Balance brought forward 63.16 63.10 24.22 17.67 13.03 7.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -4.33 0.00 1.04 0.00 0.00 0.00
P & L Balance carried down 59.02 63.16 63.10 24.22 18.87 13.03
Dividend 0.00 0.00 1.04 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -6.62 -0.51 38.31 13.99 11.76 10.90
Earnings Per Share(Adj)-Unit Curr -6.62 -0.51 30.65 5.60 4.70 4.36
Book Value 58.74 61.91 76.00 76.99 66.67 55.50
Book Value(Adj)-Unit Curr 58.74 61.91 60.80 30.80 26.67 22.20

Shareholding Pattern

  • Promoter Group

    70.60%

  • Public Share Holding

    29.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,219,537 70.60 9,219,537 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,219,537 70.60 9,219,537 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 28,012 0.21 28,012 17
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 254,187 1.95 254,187 73
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 738,738 5.66 738,738 22
Individuals holding nominal share capital up to Rs. 1 lakh 2,670,904 20.45 2,666,354 6,186
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 146,909 1.13 146,909 100
Sub Total 3,838,750 29.40 3,834,200 6,398
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,058,287 100.00 13,053,737 6,400

Company Background

ANG Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • ANG Lifesciences India Ltd
  • BSE Code : 70392.0
  • ISIN : INE236W01016

  • Incorporation Year

    2006

  • Registered Office

    Darbara Complex SCO 113 I Flr
    Dist. Shopping Centre B Block, Amritsar,
    Punjab-143001

  • Telephone

    91-0183-5070118/5070119

  • FAX

  • Chairman

  • Managing Director

    Rajesh Gupta

  • Company Secretary

    Harshita Aggarwal

  • Auditor

    Khurana Sharma & Co/Raman Wadhwa & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

ANG Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ANG Lifesciences 30.06 132.20 131.37 -3.80 1.71
Abbott India 33,260.70 6,684.73 6,409.15 49.97 44.95
Astrazeneca Phar 8,853.35 1,756.92 1,716.29 191.22 32.94
P & G Health Ltd 6,185.55 1,166.89 1,151.26 34.16 39.76
Glaxosmi. Pharma 2,840.30 3,866.05 3,723.49 51.08 58.72
Cipla 1,499.25 20,029.57 19,044.85 22.41 21.40
Amrutanjan Healt 688.35 437.58 421.23 39.16 20.84
Fermenta Biotec. 360.00 442.21 430.53 15.67 17.61
Guj. Themis Bio. 358.25 174.19 169.82 87.59 44.82
Bliss GVS Pharma 179.40 703.42 667.20 26.82 9.16
Ambalal Sarabhai 32.11 19.33 4.04 29.73 2.10